Table 3.
Clinicopathological parameters | Total (N) | OR | 95% confidence interval | p value | |
---|---|---|---|---|---|
Lower limit | Upper limit | ||||
Age (continuous) | |||||
304 | 1.007 | 0.991 | 1.024 | 0.393 | |
BMI (continuous) | |||||
259 | 0.982 | 0.950 | 1.015 | 0.280 | |
Keratinization | |||||
Yes vs. no | 174 | 1.987 | 1.011 | 3.905 | 0.046 |
Hormone use | |||||
Yes vs. no | 157 | 0.457 | 0.236 | 0.885 | 0.020 |
Hysterectomy | |||||
Yes vs. no | 167 | 0.787 | 0.190 | 3.257 | 0.740 |
Tumor size | |||||
≥T3 vs. ≤T2 | 241 | 2.234 | 1.013 | 4.927 | 0.046 |
Lymph node | |||||
N1 vs. N0 | 193 | 1.788 | 0.967 | 3.308 | 0.064 |
FIGO stage | |||||
≥IIB vs. ≤IIA2 | 297 | 2.062 | 1.274 | 3.338 | 0.003 |
Differentiation grade | |||||
≥G3 vs. ≤G2 | 272 | 0.703 | 0.434 | 1.138 | 0.151 |
Lymphovascular invasion | |||||
Yes vs. no | 150 | 1.137 | 0.597 | 2.165 | 0.697 |
Distant metastasis | |||||
Yes vs. no | 304 | 1.942 | 0.896 | 4.207 | 0.092 |